F.D.A. Looks to A.I. to Enhance Efficiency

Health
By Christina Jewett from NYT Health https://ift.tt/oZqGbvn
via IFTTT Regulation and Deregulation of Industry, Artificial Intelligence, United States Politics and Government, Federal Budget (US), Drugs (Pharmaceuticals), Coronavirus (2019-nCoV), Food, Medical Devices With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.

Comments

Popular posts from this blog

Should the Autism Spectrum Be Split Apart?

The Jarring Contradiction at the Heart of Kennedy’s Agenda